The DOUBLE-TAP study highlighted the value of post-dilatation in TAVI. @dmylotte & Soh discuss how a “double-tap” can optimise THV expansion and outcomes. #TAVI #StructuralHeart Editorial 👉 https://t.co/NhxY0gUZdD Main paper by 👉 https://t.co/OLpHUCpuTA

In this #JACCINT state-of-the-art review, read about choosing the right alternative access for #TAVR, balancing feasibility, safety & efficacy. https://t.co/ase6u9u5d6 #CardioX @thiele_holger @fjsawaya @KendraGrubb @Mo_A_W

🆕 Fibrinólisis en cardiología: Cuándo, cómo y a quién tratar. 📕 JACC 📁 Resumen del artículo en https://t.co/0FRwAqXOXr

🚨 NEW AOP in EuroIntervention! @FezziSimone et al. review the use of drug-coated balloons in coronary bifurcation PCI — offering practical guidance for standalone and hybrid strategies. @Dr_TRissanen ; @Mattialunardi ; @BernardCortese ; @FlavioRibichini ; @MdScarsini

A “double-tap” strategy after balloon-expandable TAVI improved valve expansion without increasing procedural risk. In selected anatomies, this approach achieved greater stent expansion and remained safe at 30 days. @juliusjonas_ ; @JonathonLeipsic ; @sellers_steph ; @David_Meier_

🫀💥Fundamentos fisiológicos del ventrículo derecho y curvas presión-volumen.📈📉 💖Las curvas presión-volumen (PV loops) del VD, idealmente obtenidas de forma directa o derivada, ofrecen información más avanzada sobre contractilidad, elastancia y acoplamiento con la circulación

Mitral valve interventions in elderly patients are increasing over time, driven by transcatheter therapies. Five-year mortality varied by type of intervention and was significantly influenced by frailty and social vulnerability. https://t.co/gTGsbivolj #JACCINT #cvGeri #vhdMR

All you need to know about transcatheter tricuspid therapies 📺and 📰 https://t.co/lUka2mMVYU From valve anatomy and imaging to timing of intervention and current treatment options, view these real-life case examples that show practical applications and outcomes! @ignamatsant

📊 New analysis: Elevated Lipoprotein(a) + family history = higher risk of premature ASCVD events in U.S. adults. 🔗 https://t.co/CSIc4P98ER #ASCVD #LipoproteinA #HeartHealth

What an interventional cardiologist should know about anti-thrombotics 🔗 https://t.co/T3cNAUKhMv This session replay focuses on effective inhibition during acute STEMI, latest evidence for HBR patients, and customization of DAPT in high thrombotic and low bleeding risk.

Edge-to-edge tricuspid valve repair and heart failure hospitalizations: the TRI-SPA registry #REC @lsanchisruiz @StructuralBCN @VMonivas @luisnombela @isaacpascual79 @TdBenito @igomezblazquez @ignamatsant @icruzgonzalez @ASanchezRecalde @belcid7 @manuelbarreirop @pedro_cepas

🆕 Regurgitación tricuspídea: Evaluación integral y 10 puntos clave para el clínico - Consenso ACC 2025. 📕 JACC 🔓 Resumen del artículo en https://t.co/VJJxhPhvX7 🫀 Regurgitación tricuspídea (RT): lo esencial para el clínico • Alta prevalencia en ≥75 años; RT

Clopidogrel monotherapy is superior to aspirin monotherapy for prevention of MACCE without increasing major bleeding risk & supports the use of clopidogrel over aspirin for secondary prevention in patients with #cvCAD. Learn more: https://t.co/e4yhyqiIbT #CardioX

🚨 New study in #EJPC: Exercise habits before hospitalization are significantly associated with better strength and physical function and lower post-discharge all-cause mortality in older adult patients with heart failure 💻 https://t.co/uVcD41UyyR @EJPCEiC @AboyansV

Tip-in balloon “grenadoplasty” described as a bailout for uncrossable CTO PCI. Intentional balloon burst modified calcium and enabled antegrade microcatheter passage. 🔗 https://t.co/lmmWMH7HWC #CardioTwitter #CTO #PCI #InterventionalCardiology

NEW in EuroIntervention: a State-of-the-Art review on #antithrombotictherapy in complex #PCI. Balancing ischemic protection with bleeding risk remains one of the greatest challenges in this setting. This paper discusses periprocedural and long-term management strategies,

❇️ Todo lo que debo saber sobre el manejo de la resistencia a los diuréticos Julia Gómez Diego Regístrate en CardioTeca 📝 y descarga las Diapositivas aquí⤵️ https://t.co/DgYuB0m5Zy

First #TMVR with the @EdwardsLifesci SAPIEN M3 at @cardiochuvi @Hosp_ACunqueiro! 🚀 Our 5th TMVR platform — another step forward in expanding treatment options for patients. We 💙 our #HeartTeam & #Innovation 😊

In 915 real-world #SMR patients treated with the #PASCAL #MTEER system, #aSMR & #vSMR achieved similar MR reduction & survival. Baseline ≥moderate TR was prognostic only in aSMR. https://t.co/GmGhqe75p1 #JACCINT @VictorMauriMD @philippvstein

🩺 Treating #CardiogenicShock? The SCAI Point-of-Care App puts the #SCAISHOCK Classification at your fingertips. 📲 Download the free app and be ready for 2025 #SCAISHOCK ➡️ https://t.co/KMHMdkm5Ti